Medicinal Oxygen Air Liquide Sante

Pays: Union européenne

Langue: anglais

Source: EMA (European Medicines Agency)

Achète-le

Ingrédients actifs:

oxygen

Disponible depuis:

Air Liquide Santé International

Code ATC:

QV03AN01

DCI (Dénomination commune internationale):

oxygen

Groupe thérapeutique:

Horses; Dogs; Cats

Domaine thérapeutique:

All other therapeutic products

indications thérapeutiques:

For oxygen supplementation and as a carrier gas during inhalation anaesthesia.For oxygen supplementation during recovery.

Statut de autorisation:

Withdrawn

Date de l'autorisation:

2006-12-20

Notice patient

                                Medicinal product no longer authorised
B. PACKAGE LEAFLET
12/15
Medicinal product no longer authorised
PACKAGE LEAFLET
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder
:
AIR LIQUIDE Santé INTERNATIONAL
10, rue Cognacq-Jay
75341 Paris Cedex 07
FRANCE
Manufacturer for the batch release
:
AIR LIQUIDE Santé FRANCE
ZI Est, BP 34
54181 Heillecourt Cedex
FRANCE
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Medicinal Oxygen Air Liquide Santé is an inhalation gas consisting of
100 % oxygen.
4.
INDICATION(S)
Medicinal Oxygen Air Liquide Santé can be used for oxygen
supplementation and as a carrier gas
during inhalation anaesthesia.
The veterinary medicinal product can also be used for oxygen
supplementation during recovery.
5.
CONTRAINDICATIONS
None.
6.
ADVERSE REACTIONS
None.
7.
TARGET SPECIES
Dogs, cats and horses.
13/15
Medicinal product no longer authorised
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
The precise fresh gas flow rate required by an animal during
anaesthesia and recovery should be
determined by a suitably experienced veterinarian, taking into
consideration the bodyweight and health
status of the animal and the anaesthetic equipment and agents being
used. The animal must be
monitored closely, preferably by means of a pulse oximeter, and the
flow rate adapted during
anaesthesia to meet their individual requirements.
9.
ADVICE ON CORRECT ADMINISTRATION
In-circuit oxygen meters can be used to measure the inspired oxygen
fraction and depending on the
individual animal, a level of 50 – 100 % of the veterinary medicinal
product may be required. As a
rule, and if oxygen tension cannot be measured, the inspired oxygen
fraction should
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                Medicinal product no longer authorised
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1/15
Medicinal product no longer authorised
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Medicinal Oxygen Air Liquide Santé 100 % inhalation gas for dogs,
cats and horses.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
100 % oxygen.
3.
PHARMACEUTICAL FORM
Inhalation gas.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats and horses.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For oxygen supplementation and as a carrier gas during inhalation
anaesthesia.
For oxygen supplementation during recovery.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS 
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Oxygen in concentration up to 100 % (FiO
2
1.0) should not exceed 12 hours. Oxygen in concentration
over 80 % (FiO
2
0.8) should not exceed 18 hours.
Animals with pre-existing oxygen radical damage to the lung may have
this damage exacerbated by
oxygen therapy e.g. in the treatment of paraquat poisoning.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
This veterinary medicinal product should only be used by persons who
have been fully trained to use
pressure regulators and associated equipment.
Whilst oxygen is non-flammable, it strongly supports combustion and no
naked flames should be
allowed near the container. Since even the smallest spark can cause
violent ignition, electrical
equipment capable of sparking should not be used in the vicinity of
patients receiving oxygen.
2/15
Medicinal product no longer authorised
Cylinder valves and associated equipment must not be lubricated and
must be kept entirely free from
carbon-based oils and grease because otherwise there is a risk of
spontaneous combustion and a
violent explosion may occur.
If you have been working in an oxygen-enriched atmosphere avoid
smoking, open flames or other
sources of ignition for at least 15 minutes
.
4.6
ADVERSE REACTIONS (FREQUENCY 
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient bulgare 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation bulgare 12-01-2007
Notice patient Notice patient espagnol 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation espagnol 12-01-2007
Notice patient Notice patient tchèque 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation tchèque 12-01-2007
Notice patient Notice patient danois 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation danois 12-01-2007
Notice patient Notice patient allemand 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation allemand 12-01-2007
Notice patient Notice patient estonien 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation estonien 12-01-2007
Notice patient Notice patient grec 12-01-2007
Notice patient Notice patient français 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation français 12-01-2007
Notice patient Notice patient italien 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation italien 12-01-2007
Notice patient Notice patient letton 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation letton 12-01-2007
Notice patient Notice patient lituanien 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation lituanien 12-01-2007
Notice patient Notice patient hongrois 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation hongrois 12-01-2007
Notice patient Notice patient maltais 12-01-2007
Notice patient Notice patient néerlandais 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation néerlandais 12-01-2007
Notice patient Notice patient polonais 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation polonais 12-01-2007
Notice patient Notice patient portugais 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation portugais 12-01-2007
Notice patient Notice patient roumain 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation roumain 12-01-2007
Notice patient Notice patient slovaque 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation slovaque 12-01-2007
Notice patient Notice patient slovène 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation slovène 12-01-2007
Notice patient Notice patient finnois 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation finnois 12-01-2007
Notice patient Notice patient suédois 12-01-2007
Rapport public d'évaluation Rapport public d'évaluation suédois 12-01-2007

Rechercher des alertes liées à ce produit